The results of this study reveal a novel mechanism of MALAT1 in HNSCC progression, and suggest that MALAT1 is a potential prognostic biomarker and therapeutic target for HNSCC. This evidence concerns the gene MALAT1 and head and neck squamous cell carcinoma.